Skip to content

Study for serum total cholesterol-lowering action of egg white protein containing beverage

Study for serum total cholesterol-lowering action of egg white protein containing beverage - Egg white cholesterol study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1090220279
Enrollment
88
Registered
2017-03-13
Start date
2006-05-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normo- and mildly hypercholesterolemic subjects

Interventions

Intervention type:BEHAVIOUR Name of intervention:KYP2-2006-0320,KYP2-2006-0320,KYP2-2006-0320 Dose form / Japanese Medical Device Nomenclature:OTHER,OTHER,OTHER Drink,Drink,Drink Route of administrati

Sponsors

Kewpie Corporation
Lead Sponsor
SOUKEN
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Japanese males with mild hypercholesterolemia of at least 20 years and not more than 65 years of age, (2) not undergoing treatment for hyperlipidemia, (3) not undergoing treatment for diabetes, (4) had no subjective symptoms of gout, (5) capable of filling out necessary forms such as self-diagnosis forms, and (6) capable of visiting a designated institution as scheduled.

Exclusion criteria

Exclusion criteria: (1) those who were taking drugs considered to potentially affect test results (e.g., anti-hyperlipidemic agents, anti-diabetic agents, oral corticosteroid formulations, and antihypertensive agents), (2) were regularly consuming foods for specified health uses considered to potentially affect test results, (3) were excessively consuming alcohol, (4) suspected to develop allergic reactions (particularly those allergic to egg and milk), (5) those who were participating in other clinical studies, (6) had a history of serious liver damage, kidney damage, or myocardial infarction, (7) had a history of or currently had hepatitis, and (8) had serious anemia. The candidates who fulfilled the abovementioned criteria then underwent a screening survey.

Design outcomes

Primary

MeasureTime frame
Serum total cholesterol and LDL-cholesterol levels

Countries

Japan

Contacts

Public ContactRyosuke Matsuoka

Kewpie corporation

ryosuke_matsuoka@kewpie.co.jp+81-3-5384-7759

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026